DHI vs INTS
DR Horton Inc (DHI) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. Revenue was down 6.9% from 2024-09-30 to 2025-09-30. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
INTS does not have a complete income-statement cache yet.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. INTS currently screens at market cap $7.7M.
Not investment advice. Open the DHI and INTS stock pages for the full models.
Not investment advice.